Home » Stocks » TFFP

TFF Pharmaceuticals, Inc. (TFFP)

Stock Price: $13.37 USD -0.91 (-6.37%)
Updated Oct 28, 2020 4:00 PM EDT - Market closed
After-hours: $12.71 -0.66 (-4.94%) Oct 28, 4:54 PM

Stock Price Chart

Key Info

Market Cap 297.97M
Revenue (ttm) n/a
Net Income (ttm) -15.11M
Shares Out 22.29M
EPS (ttm) -2.60
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Oct 28, 2020
Last Price $13.37
Previous Close $14.28
Change ($) -0.91
Change (%) -6.37%
Day's Open 13.90
Day's Range 12.96 - 13.98
Day's Volume 314,286
52-Week Range 3.44 - 19.00

More Stats

Market Cap 297.97M
Enterprise Value 276.04M
Earnings Date (est) n/a
Ex-Dividend Date n/a
Shares Outstanding 22.29M
Float 16.70M
EPS (basic) -4.60
EPS (diluted) -2.60
FCF / Share n/a
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 370,808
Short Ratio 0.98
Short % of Float 2.22%
Beta n/a
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio n/a
PB Ratio 15.13
Revenue n/a
Operating Income -15.27M
Net Income -15.11M
Free Cash Flow n/a
Net Cash 21.92M
Net Cash / Share 0.98
Gross Margin n/a
Operating Margin n/a
Profit Margin n/a
FCF Margin n/a
ROA -52.53%
ROE -88.84%
ROIC 4,170.50%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Forecasts

Analyst Ratings (2)

Buy 2
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: Buy

Price Target

$20.50*
(53.33% upside)
Low
18.0
Current: $13.37
High
23.0
Target: 20.50
*Average 12-month price target from 2 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year201920182017
Revenue---
Operating Income-11.99-3.90-0.18
Net Income-11.87-3.84-0.18
Shares Outstanding6.903.48-
Earnings Per Share-5.31-1.31-
Operating Cash Flow-11.22-2.13-0.19
Free Cash Flow-11.22-2.13-0.19
Cash & Equivalents28.0910.26-
Net Cash / Debt28.0910.26-
Assets29.1910.40-
Liabilities1.541.16-
Book Value27.64-3.24-
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name TFF Pharmaceuticals, Inc.
Country United States
Employees 4
CEO Glenn R. Mattes

Stock Information

Ticker Symbol TFFP
Stock Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Unique Identifier NASDAQ: TFFP
IPO Date October 25, 2019

Description

TFF Pharmaceuticals, an early-stage biopharmaceutical company, focuses on developing and commercializing drug products based on its patented Thin Film Freezing, or TFF, technology platform. It intends to initially focus on the development of inhaled dry powder drugs for the treatment of pulmonary diseases and conditions. The company has a research collaboration with the University of Georgia's Center for Vaccines and Immunology (CVI), along with the University of Texas at Austin (UT Austin), to evaluate the immunogenicity of universal influenza vaccines; and cooperative research and development agreement with United States Army Medical Research Institute of Infectious Diseases for use of its thin film freezing technology platform. TFF Pharmaceuticals, Inc. was founded in 2018 and is based in Austin, Texas.